Watson Oral Contraceptives Brands

U.S. Prescribing Information

This section of oralcontraceptives.com contains product prescribing information and is intended for US Healthcare Professionals.

Brevicon®

(norethindrone and ethinyl estradiol tablets, USP)

Jolivette®

(norethindrone tablets)

Leena®

(norethindrone and ethinyl estradiol tablets, USP)

Levora®

(levonorgestrel and ethinyl estradiol tablets, USP)

Low-Ogestrel®

(norgestrel and ethinyl estradiol tablets, USP)

LuteraTM

(levonorgestrel and ethinyl estradiol tablets, USP)

Microgestin®Fe 1/20

(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)

Microgestin® 1/20

(norethindrone acetate and ethinyl estradiol tablets, USP)

Microgestin®Fe 1.5/30

(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)

Microgestin®1.5/30

(norethindrone acetate and ethinyl estradiol tablets, USP)

MonoNessa®

(norgestimate and ethinyl estradiol tablets, USP)

Necon®

(norethindrone and ethinyl estradiol tablets, USP)

Necon® 7/7/7

(norethindrone/ethinyl estradiol, USP)

Nora-Be®

(norethindrone tablets, USP)

Norinyl 1+35®

(norethindrone and ethinyl estradiol tablets, USP)

Norinyl 1+50®

(norethindrone and mestranol tablets, USP)

Nor-QD®

(norethindrone tablets, USP)

Norinyl®

(norethindrone and ethinyl estradiol tablets, USP)

Ogestrel®

(norgestrel and ethinyl estradiol tablets, USP)

ReclipsenTM

(desogestrel and ethinyl estradiol tablets, USB)

TriNessa®

(norgestimate and ethinyl estradiol tablets, USP)

Tri-Norinyl®

(norethindrone and ethinyl estradiol tablets, USP)

Trivora®

(levonorgestrel and ethinyl estradiol tablets, USP)

Zovia®

(ethynodiol diacetate and ethinyl estradiol tablets, USP)

*ferrous fumarate tablets are not USP for dissolution and assay.

SAFETY INFORMATION
Women who use oral contraceptives (OCs) should be strongly advised not to smoke due to the increased risk of cardiovascular side effects. Serious risks reported with the use of OCs include blood clots, stroke, and heart attacks. OCs are contraindicated in women with thrombophlebitis, thromboembolic disorders, breast cancer, hepatic or estrogen-dependent neoplasia, cerebrovascular or coronary artery disease, jaundice, or undiagnosed genital bleeding. OCs do not protect against HIV infection (AIDS) or other sexually transmitted diseases.